Evidence supporting the use of: Spirulina
For the health condition: Cirrhosis of the Liver

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Synopsis: Spirulina, a blue-green algae, has been investigated for its potential supportive role in liver health, including cirrhosis. Some preclinical studies (in vitro and animal models) suggest that spirulina may exert hepatoprotective effects due to its antioxidant, anti-inflammatory, and immunomodulatory properties. Research indicates that spirulina can reduce oxidative stress markers and improve liver enzyme profiles in animal models of liver injury, including those induced by toxins that mimic cirrhosis. However, human clinical data are sparse and generally limited to small studies or case reports. One small clinical trial found that spirulina supplementation improved certain biochemical parameters in patients with chronic liver diseases, but the evidence is not robust or specific enough to conclusively recommend spirulina as a treatment for cirrhosis. Instead, spirulina may provide some supportive benefits as an adjunct to medical management, potentially helping to mitigate oxidative damage and inflammation associated with liver disease.

Overall, while there is some scientific investigation into spirulina's liver-protective effects, the quality and quantity of evidence for its use in treating or supporting cirrhosis in humans are limited. Larger, well-designed clinical trials are required to establish efficacy and safety. As such, the scientific evidence supporting spirulina for cirrhosis is rated as weak (2 out of 5), and it should not replace established medical therapies.

More about spirulina
More about Cirrhosis of the Liver